17929119

Source:http://linkedlifedata.com/resource/pubmed/id/17929119

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0238198, umls-concept:C1514983, umls-concept:C2349975
pubmed:issue	5
pubmed:dateCreated	2007-10-11
pubmed:abstractText	Recent breakthroughs regarding the oncogenesis of gastrointestinal stromal tumors (GISTs) have led to the wider use of imatinib mesylate in the treatment of advanced GISTs. However, the role of imatinib in an adjuvant setting has yet to be established, mainly owing to the lack of an accurate system to prognosticate recurrences and/or metastases. The aims of this study were to identify factors prognostic for an unfavorable postoperative outcome, and to enhance the current NIH-consensus risk-group stratification system (Fletcher's system).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9616295
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/imatinib
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1341-9625
pubmed:author	pubmed-author:HirotaSeiichiS, pubmed-author:NakajimaKiyokazuK, pubmed-author:NishidaToshirouT, pubmed-author:NishitaniAkikoA, pubmed-author:SawaYoshikiY, pubmed-author:SoumaYoshihitoY, pubmed-author:TakahashiTsuyoshiT
pubmed:issnType	Print
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	369-74
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:17929119-Adult, pubmed-meshheading:17929119-Aged, pubmed-meshheading:17929119-Aged, 80 and over, pubmed-meshheading:17929119-Antineoplastic Agents, pubmed-meshheading:17929119-Female, pubmed-meshheading:17929119-Follow-Up Studies, pubmed-meshheading:17929119-Gastrointestinal Stromal Tumors, pubmed-meshheading:17929119-Humans, pubmed-meshheading:17929119-Male, pubmed-meshheading:17929119-Middle Aged, pubmed-meshheading:17929119-Neoplasm Staging, pubmed-meshheading:17929119-Piperazines, pubmed-meshheading:17929119-Prognosis, pubmed-meshheading:17929119-Protein-Tyrosine Kinases, pubmed-meshheading:17929119-Pyrimidines, pubmed-meshheading:17929119-Retrospective Studies, pubmed-meshheading:17929119-Risk Factors, pubmed-meshheading:17929119-Survival Rate, pubmed-meshheading:17929119-Treatment Outcome
pubmed:year	2007
pubmed:articleTitle	An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors.
pubmed:affiliation	Department of Surgery, Osaka University Graduate School of Medicine, 2-2, E1, Yamadaoka, Suita, Osaka 565-0871, Japan.
pubmed:publicationType	Journal Article